Over 4 mln COVID-19 vaccine doses from China's CNBG administered in emergency use

More than 4 million COVID-19 vaccine doses from China National Biotec Group (CNBG) have been administered as of Jan. 4 via China's emergency use program, the company's parent firm said late on Thursday. Two vaccines respectively from two institutes owned by CNBG, a unit of state-backed China National Pharmaceutical Group (Sinopharm), are included in China's emergency vaccination scheme, which was officially started in July targeting specific groups of people facing a high infection risk.

Reuters | Updated: 09-01-2021 06:34 IST | Created: 09-01-2021 06:34 IST
Over 4 mln COVID-19 vaccine doses from China's CNBG administered in emergency use

More than 4 million COVID-19 vaccine doses from China National Biotec Group (CNBG) have been administered as of Jan. 4 via China's emergency use program, the company's parent firm said late on Thursday.

Two vaccines respectively from two institutes owned by CNBG, a unit of state-backed China National Pharmaceutical Group (Sinopharm), are included in China's emergency vaccination scheme, which was officially started in July targeting specific groups of people facing a high infection risk. "No serious adverse reaction was reported in large-scale emergency use of Sinopharm's COVID-19 vaccines," Sinopharm said on Chinese social media WeChat.

A total of 72,000 people have been overseas after receiving China's emergency jabs, including around 40% of more than 5,000 staffers on one Chinese firm's Pakistan-based project, Sinopharm said. None of the vaccinated diplomats, international organization representatives or employees at Chinese firms, who went to countries of high virus risk, contracted the COVID-19 disease caused by the new coronavirus, despite their close contact with infected locals, Sinopharm said.

The firm did not break down the number of doses for each of the two vaccines used in the emergency program. Aside from CNBG's two vaccines, China's emergency use program also includes a potential shot from Sinovac Biotech . A fourth candidate from CanSino Biologics was approved for use in Chinese military personnel.

The vaccine from CNBG's unit Beijing Institute of Biological Products was approved in China for broader use among the general public last year. The two-dose regimen is 79.34% effective against the disease, according to interim analysis from late-stage clinical trials overseas. Although the CNBG vaccine's protection rate is lower than the more than 90% efficacy of vaccines from Moderna Inc or Pfizer Inc and its partner BioNTech SE, it can be transported and stored at less demanding temperatures.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)


TRENDING

OPINION / BLOG / INTERVIEW

Why unequal access to coronavirus vaccines is a threat to us all

... ...

India’s love affair with fossil fuels: the path to sustainable development?

... ...

Videos

Latest News

New Zealand's Auckland starts second lockdown in month

Auckland, New Zealands biggest city, woke up on Sunday morning to a second lockdown in a month as health authorities try to rein in a coronavirus cluster of the more contagious UK variant. The seven-day lockdown, announced late Saturday by ...

Doctor appears in court video call while performing surgery

The Medical Board of California said it would investigate a plastic surgeon who appeared in a videoconference for his traffic violation trial while operating.The Sacramento Bee reports Dr. Scott Green appeared Thursday for his Sacramento Su...

UK’s Sunak to provide 5 bln stg of grants to pandemic hit businesses in budget

British finance minister Rishi Sunak will announce 5 billion pounds 7 billion of additional grants to help businesses hit hard by pandemic lockdowns in his budget statement next week, the government said on Saturday. Shops, bars, clubs, hot...

Brazil registers over 1,300 COVID-19 deaths for fifth straight day

Brazil registered 1,386 COVID-19 deaths on Saturday and 61,602 additional cases, according to data released by the nations Health Ministry.The South American country has suffered an enduring second wave since November, and infection rates h...

Give Feedback